• Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment
• Melatonin in autism spectrum disorders: a systematic review and meta-analysis
• Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder
• Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study
• Metabolomic Signatures of Autism Spectrum Disorder
• MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
• Mitochondria May Mediate Prenatal Environmental Influences in Autism Spectrum Disorder
• Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study
• Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study
• Mitochondrial disease in 22q13 duplication syndrome
• Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders
• Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments
• Mitochondrial Dysfunction in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
• Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study
• Mitochondrial Dysfunction Is Inducible in Lymphoblastoid Cell Lines From Children With Autism and May Involve the TORC1 Pathway
• Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome
• Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
• Mitochondrial morphology is associated with respiratory chain uncoupling in autism spectrum disorder
• Modern Biomarkers for Autism Spectrum Disorder: Future Directions
• Modulation of Immunological Pathways in Autistic and Neurotypical Lymphoblastoid Cell Lines by the Enteric Microbiome Metabolite Propionic Acid